DIFFERENTIATING AGENTS IN THE TREATMENT OF HUMAN MALIGNANCIES

被引：32

作者：

CHESON, BD ^{[1
]}

JASPERSE, DM ^{[1
]}

CHUN, HG ^{[1
]}

FRIEDMAN, MA ^{[1
]}

机构：

[1] EMMES CORP, POTOMAC, MD 20854 USA

来源：

CANCER TREATMENT REVIEWS | 1986年 / 13卷 / 03期

关键词：

D O I：

10.1016/0305-7372(86)90001-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：129 / 145

页数：17

共 191 条

[11]

BERAN M, 1985, P AN M AM SOC CLIN, V4, pA678

[12]

BESA E, 1985, BLOOD, V66, pA663

[13]

BODNER AJ, 1981, J NATL CANCER I, V67, P1025

[14]

BOGDEN AE, 1985, P AACR, V26, pA134

[15]

BOSS MA, 1980, BLOOD, V56, P910

[16]

BOYD AW, 1984, BLOOD, V63, P384

[17] INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].

BREITMAN, TR ;

SELONICK, SE ;

COLLINS, SJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940

[18] PROTECTION AGAINST HYPERTHERMIC CELL KILLING OF MOUSE MAMMARY ADENOCARCINOMA CELLS-INVITRO BY N,N-DIMETHYLFORMAMIDE [J].

BRENNER, HJ ;

LEITH, JT ;

DEWYNGAERT, JK ;

DEXTER, DL ;

CALABRESI, P ;

GLICKSMAN, AS .

RADIATION RESEARCH, 1981, 88 (02) :291-298

[19]

BUESSOW SC, 1984, J BIOL RESP MODIF, V3, P653

[20]

CASE DC, 1985, P AACR, V26, pA697

← 1 2 3 4 5 6 7 8 9 10 →